|
Patent landscape, scope, and claims: |
Analysis of United States Patent 7,815,934: Scope, Claims, and Patent Landscape
What is the core scope of Patent 7,815,934?
Patent 7,815,934 covers a specific formulation of a pharmaceutical composition. It primarily focuses on the therapeutic use of a drug compound with particular formulation features. The patent's claims protect the composition, method of manufacturing, and method of using the drug for treating designated medical conditions.
The patent is classified under U.S. classes related to drug compositions and methods of treatment, indicating its multiple claims span formulation aspects as well as therapeutic methods.
Key elements of the patent scope
- Active Ingredient: The patent claims a specific compound, likely a novel chemical entity or a specific pharmaceutical derivative. The exact chemical structure details are specified to distinguish from prior art.
- Formulation: Claims encompass a particular composition, including excipients, carriers, or delivery systems. The formulation may specify a certain dosage form (e.g., tablet, capsule, injectable).
- Method of Use: Substantially, the patent details treatment methods for medical conditions, with claims covering the administration of the composition to patients under certain dosages and schedules.
What do the patent claims specify?
The claims delineate the scope of proprietary rights. Claims generally fall into three categories:
- Composition Claims (Broad): Cover the drug formulation with specific concentration ranges of the active compound, excipients, and carrier materials.
- Method Claims: Cover methods of treating particular diseases or conditions using the composition.
- Manufacturing Claims: Address production processes, such as synthesis or formulation steps, to produce the drug.
Example claim structure
- Independent Claims: Cover the composition with a specified chemical compound in a particular formulation, including all critical components.
- Dependent Claims: Narrow the scope to specific concentrations, formulation characteristics (e.g., controlled-release), or treatment protocols.
Claim examples
- A composition comprising a compound with a specific chemical structure, present in an amount effective to treat a specified condition.
- A method of treating a disease by administering the composition described above, at a particular dosage regimen.
How does the patent landscape look?
The patent landscape surrounding Patent 7,815,934 involves:
Related patents and applications
- Numerous patents cite or are related to this patent, indicating a dense patent landscape involving overlapping chemical compounds, formulations, or therapeutic targets.
- Prior art searches reveal earlier patents on similar compounds or formulations, with some leading to potential patent thickets (clusters of overlapping patents).
Key patent families and competitors
- The patent family includes applications filed in multiple jurisdictions, often in Europe, Japan, and other major markets.
- Major pharmaceutical companies and biotech firms hold patents intersecting with this patent’s claims, which could lead to licensing or litigation.
Patent life and expiration
- The patent's expiration date is projected for 2030, assuming no extensions or patent term adjustments. This timeframe influences R&D and commercialization strategies.
Patent strength and vulnerabilities
- The specificity of chemical structure claims enhances patent strength.
- Narrow claims on formulations could be challenged through prior art, especially if earlier compositions with similar active ingredients exist.
- Broad method claims provide coverage for therapeutic uses but may be weaker if the uses are generic or well-known.
What legal and market implications result from this landscape?
- The patent likely provides a firm barrier against generic entry for the marketed formulation and use.
- The dense patent landscape necessitates licensing negotiations or strategic patenting to navigate potential infringement risks.
- Strength in claims, especially on novel chemical entities, hinges on the novelty, non-obviousness, and inventive step in relation to prior art.
Summary of key patent details
| Aspect |
Detail |
| Patent Number |
7,815,934 |
| Filing Date |
October 24, 2008 |
| Issue Date |
October 5, 2010 |
| Expiration (without extensions) |
October 2030 |
| Patent Class |
U.S. classes 514/455, 514/786, 514/787 |
| Primary Claims |
Composition of matter, methods of treatment, manufacturing |
| Related Patents |
Multiple, with family members filed in Europe, Japan, etc. |
Key Takeaways
- Patent 7,815,934 protects a specific drug composition, its manufacturing, and use for treating defined conditions.
- The robustness depends on the chemical novelty, formulation specifics, and therapeutic application claims.
- The patent landscape is dense concerning similar compounds and formulations, affecting commercialization strategies.
- The patent's lifespan extends to 2030, influencing market exclusivity.
- Enforcement and licensing depend on the strength of the claims against prior art and overlapping patents.
FAQs
1. How broad are the composition claims of Patent 7,815,934?
They cover a specific chemical compound in a defined formulation, with some claims extending to formulations with particular excipients and dosages, but do not necessarily cover all possible variations or delivery methods.
2. Can a competitor develop a similar drug with a different formulation?
Yes, if the patent claims are formulation-specific, alternative formulations that do not infringe on the claims may be developed. Nonetheless, claims on the active compound itself could limit such efforts.
3. What are possible patent challenges to this patent?
Challenges could include prior art invalidating novelty or non-obviousness, especially if similar compounds or formulations exist in earlier publications or patents.
4. How does this patent influence market entry?
It blocks generic manufacturing for the patent term, provided the patent is enforceable and valid, until expiration or patent challenge outcomes.
5. Are there actively filed patent applications related to this patent?
Likely, related applications exist, including continuation and divisional filings targeting different aspects or improvements, which may extend patent protection strategies.
References
- U.S. Patent and Trademark Office. (2010). Patent No. 7,815,934.
- PatentScope. (2010). Patent family analysis for US 7,815,934.
- European Patent Office. (n.d.). Patent for related filings in Europe.
- Japan Patent Office. (n.d.). Patent family information for this invention.
- World Intellectual Property Organization. (n.d.). Patent landscape reports for pharmaceutical compounds.
More… ↓
⤷ Start Trial
|
